✦ LIBER ✦

Overview of clinical trials employing antibody-targeted superantigens

✍ Scribed by R.Katherine Alpaugh; Louis M Weiner; Robert Persson; Bo Persson

Book ID: 114176495
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 177 KB
Volume: 31
Category: Article
ISSN: 0169-409X
DOI: 10.1016/s0169-409x(97)00098-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New targeted treatments in lung cancer —

New targeted treatments in lung cancer — overview of clinical trials

✍ Korfee, S.; Gauler, T.; Hepp, R.; Pöttgen, C.; Eberhardt, W. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Clinical trials of targeted toxins

✍ Arthur E. Frankel; Edward P. Tagge*; Mark C. Willingham† 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 113 KB

T cell killing of human colon carcinomas

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens

✍ Peter A. Lando; Mikael Dohlsten; Gunnar Hedlund; Eva Åkerblom; Terje Kalland 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 619 KB

An overview of clinical trials

✍ Kathleen Rich 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Overview of clinical trials with urapidi

Overview of clinical trials with urapidil

✍ C.Edward Schook; Heinz Radtke; Wilhelm Wurst; Gisela Thieme 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Overview: Current status of clinical tri

Overview: Current status of clinical trials

✍ John R. Durant 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

I existing clinical trials or attempt to highlight the exciting new developments emerging from the laboratories of our basic scientists and today's clinical trials. Likewise I do not decry the still daunting problems which face those concerned with the common, therapy-resistant cancers which kill so